Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Comment by Summerhill68on Dec 24, 2021 7:48am
173 Views
Post# 34260333

RE:86 millions order from Québec

RE:86 millions order from QuébecThis astounding. The need for rapid testing today should have this compay in the if not the lead for domestic/International sales but that never happens. Trudeau/Biden preach the need for greater supply of Rapid tests but the only companies getting the advantage is Abbott and Roche it seems. So what in hell is MIR not doing right. They have never been right in getting into the supply chain at the right time. WHY WHY WHY not MIR. There has to be a major problem with this company in this market place. What is it?? If its nothing other than we are the only ones who know about the potential of this test then We need to contact our Federal/Provincial Health people and educate them because they don't seem to know about MIR. The delay in gettting FDA final approval is on MIR and if this is the issue then this company is going no where.IMO
<< Previous
Bullboard Posts
Next >>